Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: The ShortCut™ Study Protocol [NA]

View source ↗

Summary

The ShortCut study protocol has completed and posted results related to evaluating risk of coronary obstruction after transcatheter aortic valve replacement (TA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pi-cardia | Conditions: Risk of Coronary Obstruction Following Transcatheter Aortic Valve Replacement (TAVR) Procedure | NA | Status: COMPLETED | Results posted: 2025-02-03